Prozac Increased Risk Of Bone Fractures, Failed To Increase Functioning After Strokes: Study

New research suggests that use of Prozac following a stroke does not help a person recover, and fails to result in any less disability, yet may increase their risk of suffering a bone fracture. 

In a study published in the medical journal The Lancet on January 19, researchers from the University of Edinburgh evaluated the risks and effectiveness of Prozac (fluoxetine) use among individuals who suffered a stroke, as prior findings have suggested the selective serotonin reuptake inhibitor (SSRI) may help reduce disability.

Researchers recruited patients from 103 hospitals in the UK to participate in the FOCUS study, which was a double-blind randomized control trial funded by the Stroke Association and the National Institute for Health Research.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Patients were 18 and older, with a clinical stroke diagnosis and focal neurological deficits. They were enrolled between two and 15 days after suffering a stroke. They were then randomly assigned to take 20 mg of Prozac or a placebo daily for six months.

More than 3,000 patients were recruited, about half of whom were given Prozac and the other half were given a placebo, with no active drug.

Overall, researchers noted no difference in physical disability between patients who took Prozac and those who took the placebo.

Patients given Prozac were not less likely to suffer disability or recover any better than those who didn’t take the drug. More so, patients given Prozac suffered more bone fractures than the placebo group.

Researchers noted the group given Prozac had less occurrences of depression, but it did not improve functional ability or help promote recovery.

The findings do not support the practice of giving stroke patients Prozac to simply help treat depression after stroke, according to researchers, as the improvements were moderate.

“Fluoxetine 20 mg given daily for 6 months after acute stroke does not seem to improve functional outcomes,” wrote study authors. “Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures. These results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function.”


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims
Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims (Posted 2 days ago)

Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states